Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
DHX36 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DGUOK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928100 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
AZIN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA0087 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL23R - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TLDC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SGCD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXW7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GAL3ST3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF578 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCKAP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STX6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HDAC8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RYBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MS4A14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on